| Group I No. = 117 | Group II No. = 199 | Test value | p-value | Sig. | |
ER | Negative | 34 (29.1%) | 53 (26.6%) | 0.229* | 0.633 | NS |
Positive | 83 (70.9%) | 146 (73.4%) | ||||
PR | Negative | 37 (33.0%) | 55 (27.6%) | 0.791* | 0.374 | NS |
Positive | 80 (67.0%) | 144 (72.4%) | ||||
HER2/neu | Negative | 88 (75.5%) | 147 (74.0%) | 0.082* | 0.774 | NS |
Positive | 29 (24.5%) | 52 (26.0%) | ||||
Ki 67 | Negative Positive | 13 (11.1%) 32 (27.4%) | 22 (11.1%) 61 (30.7%) | 0.083 | 0.773 | NS |
Molecular subtype | HR+/Her2− HR+/Her2+ Her+ TN | 68 (58%) 16 (13.7%) 12 (10.3%) 21 (18%) | 113 (56.8%) 35 (17.6%) 19 (9.6%) 32 (16%) | 0.885* | 0.829 | NS |